NCT06445335Active, not recruiting
Prevalence of NAFLD in T2DM Patients
The Prevalence of Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus Patients Followed at Ziekenhuis Oost-Limburg, Genk, Belgium
Source: ClinicalTrials.gov · Last updated 2 Dec 2025
Brief summary (registry, in English)
To determine the prevalence of non-alcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes mellitus (T2DM).
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 385 (estimated)
- First submitted
- 21 May 2024
- Start date
- 1 Mar 2019
- Primary completion date
- 1 Nov 2026
- Lead sponsor
- Ziekenhuis Oost-Limburg
- NCT number
- NCT06445335
What you commit to
- Study type: Interventional
- Planned participants: 385
- From 1 Mar 2019 to the primary completion date, 1 Nov 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Exclusion of other causes of liver disease and secondary causes of steatosis
Other
- Excessive alcohol use
Who the study is looking for
- ≥ 18 years of age
- Having type 2 diabetes mellitus (T2DM)
- Written informed consent obtained
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ziekenhuis Oost-Limburg Coordinator of this site? Confirm its status | Genk | Belgium | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.